RU2004136472A - METHOD FOR TREATMENT OF CHRONIC DIFFUSAL LIVER DISEASES - Google Patents

METHOD FOR TREATMENT OF CHRONIC DIFFUSAL LIVER DISEASES Download PDF

Info

Publication number
RU2004136472A
RU2004136472A RU2004136472/14A RU2004136472A RU2004136472A RU 2004136472 A RU2004136472 A RU 2004136472A RU 2004136472/14 A RU2004136472/14 A RU 2004136472/14A RU 2004136472 A RU2004136472 A RU 2004136472A RU 2004136472 A RU2004136472 A RU 2004136472A
Authority
RU
Russia
Prior art keywords
treatment
liver diseases
chronic
diffusal
intrahepally
Prior art date
Application number
RU2004136472/14A
Other languages
Russian (ru)
Other versions
RU2283113C2 (en
Inventor
Елена Рэмовна Черных (RU)
Елена Рэмовна Черных
Ольга Юрьевна Леплина (RU)
Ольга Юрьевна Леплина
Александр Анатольевич Останин (RU)
Александр Анатольевич Останин
Наталь Михайловна Старостина (RU)
Наталья Михайловна Старостина
Александр Иванович Пальцев (RU)
Александр Иванович Пальцев
Игорь Андреевич Лисуков (RU)
Игорь Андреевич Лисуков
Александр Дмитриевич Кулагин (RU)
Александр Дмитриевич Кулагин
Владимир Александрович Козлов (RU)
Владимир Александрович Козлов
Original Assignee
Государственное учреждение научно-исследовательский институт клинической иммунологии СО РАМН (RU)
Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное учреждение научно-исследовательский институт клинической иммунологии СО РАМН (RU), Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН filed Critical Государственное учреждение научно-исследовательский институт клинической иммунологии СО РАМН (RU)
Priority to RU2004136472/14A priority Critical patent/RU2283113C2/en
Publication of RU2004136472A publication Critical patent/RU2004136472A/en
Application granted granted Critical
Publication of RU2283113C2 publication Critical patent/RU2283113C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ лечения хронических диффузных заболеваний печени, заключающийся в использовании гепатопротекторов и трансплантации стволовых клеток, отличающийся тем, что используют стволовые клетки, непосредственно выделенные из аспирата костного мозга пациента, которые вводят внутривенно и внутрипеченочно под ультразвуковым контролем, содержащие количество СD34-позитивных клеток, достаточное для достижения клинического эффекта за счет купирования печеночно-клеточной недостаточности, в том числе у больных циррозом печени.A method for the treatment of chronic diffuse liver diseases, which consists in the use of hepatoprotectors and stem cell transplantation, characterized in that they use stem cells directly isolated from a patient’s bone marrow aspirate, which are administered intravenously and intrahepally under ultrasound control, containing an amount of CD34-positive cells sufficient to achieving a clinical effect due to the relief of hepatic cell failure, including in patients with cirrhosis.
RU2004136472/14A 2004-12-14 2004-12-14 Method for treating the cases of chronic diffuse hepatic diseases RU2283113C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2004136472/14A RU2283113C2 (en) 2004-12-14 2004-12-14 Method for treating the cases of chronic diffuse hepatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004136472/14A RU2283113C2 (en) 2004-12-14 2004-12-14 Method for treating the cases of chronic diffuse hepatic diseases

Publications (2)

Publication Number Publication Date
RU2004136472A true RU2004136472A (en) 2006-05-20
RU2283113C2 RU2283113C2 (en) 2006-09-10

Family

ID=36658285

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004136472/14A RU2283113C2 (en) 2004-12-14 2004-12-14 Method for treating the cases of chronic diffuse hepatic diseases

Country Status (1)

Country Link
RU (1) RU2283113C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2650209C1 (en) * 2017-08-08 2018-04-11 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации (ФГБУ "ФНЦТИО им. ак. В.И. Шумакова" Минздрава России) Method of correction of hepatic insufficiency in the experiment
RU2766787C1 (en) * 2021-07-08 2022-03-15 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Method of treating acute bacterial cholangiohepatitis in cats
EP4257142A1 (en) * 2022-04-08 2023-10-11 Saparbayev, Samat S. The method of treatment of chronic diffuse liver lesions by intravenous transplantation of stem cells

Also Published As

Publication number Publication date
RU2283113C2 (en) 2006-09-10

Similar Documents

Publication Publication Date Title
MX342791B (en) Elisa for vegf.
TR201903587T4 (en) Compounds for increasing telomerase activity.
EA200700886A1 (en) CONNECTION OF TIADIAZOLE AND ITS APPLICATION
Zhao et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction
WO2005001080A3 (en) Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
EP1742643A4 (en) Modulation of glucose-6-phosphatase translocase expression
ATE395924T1 (en) RESTORATION OF DESTROYED TISSUE USING MULTIPOTENT CELLS
EP2503338A3 (en) CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
WO2005111204A3 (en) Porcine forssman synthetase cdna and polypeptide
ES2521674T3 (en) Methods of treatment of hyperuricemia and associated pathological conditions
CN105435230A (en) Application of O-GlcNAc glycosylation modification in preventing and treating hepatic fibrosis
RU2004136472A (en) METHOD FOR TREATMENT OF CHRONIC DIFFUSAL LIVER DISEASES
WO2007015094A3 (en) Use of peptides for imaging blood clots
WO2008011133A3 (en) Compositions of late passage mesenchymal stem cells (mscs)
Bogdanić et al. Giant basal cell carcinoma of the back: a case report and review of the literature
RU2006100561A (en) METHOD FOR TREATING ONCOLOGICAL DISEASES
RU2256925C1 (en) Method for predicting the flow of chronic hepatitis c
Oberndorfer et al. P02. 01 ABTR-SANO Real-World Pattern of Care Study on Glioblastoma in the Austrian Population
Badin et al. Multiphasic changes in smooth muscle Ca2+ transporters during the progression of coronary atherosclerosis
Dinh et al. Inhalation Of Stem Cell-Secreted Factors Mitigates Disease And Promotes Regeneration In A Rodent Model Of Pulmonary Fibrosis
Khamrabaeva Features of treatment of chronic pancreatitis with of the pancreatic gland
RU2006134818A (en) METHOD FOR PREDICTING DEVELOPMENT OF FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC VIRAL HEPATITIS WITH
RU2006127134A (en) METHOD FOR TREATING DISEASES
Jeon et al. VDJ Gene Usage among B-Cell Receptors in ABO-incompatible Kidney Transplantation Determined by RNA-seq Transcriptomic Analysis
Terzi et al. Genomic Changes in Pediatric Renal Transplant Patients Detected by aCGH